Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Effect of Vision Therapy/Orthoptic on Motor & Sensory Status of the 3 to 7 Years Old Strabismic Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified June 2009 by Shahid Beheshti University of Medical Sciences.
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
Shahid Beheshti University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT00917982
First received: June 10, 2009
Last updated: NA
Last verified: June 2009
History: No changes posted
  Purpose
Vision therapy (VTO) is a group of non-surgical treatment helping patients in 3 subjects;1)increasing the the visual acuity 2)improving the mechanical skills resulting in increasing the power of extraocular muscles,biocular vision,peripheral vision 3) increasing the perceptual skills making the brain to percept the colour and visual memory better.In this study we are going to compare the effect of vision therapy /orthoptic on motor & sensory of the 3 to 7 years old strabismic patients

Condition Intervention Phase
Strabismus
Other: vision therapy
Phase 1

Study Type: Interventional
Official Title: The Effect of Vision Therapy/Orthoptic on Motor & Sensory Status of the 3 to 7

Resource links provided by NLM:


Further study details as provided by Shahid Beheshti University of Medical Sciences:

Arms Assigned Interventions
Vision therapy Other: vision therapy

  Eligibility

Ages Eligible for Study:   3 Years to 7 Years   (Child)
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • 3<age<7
  • Congenital isotropia

Exclusion Criteria:

  • Muscular disease
  • General ocular and systemic disease
  • Seizure
  • Visual Acuity < 60/20
  • Nystagmus
  • Follow up less than 3 months after surgery
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00917982

Locations
Iran, Islamic Republic of
Ophthalmic Research Center
Tehran, Iran, Islamic Republic of, 166666
Sponsors and Collaborators
Shahid Beheshti University of Medical Sciences
  More Information

ClinicalTrials.gov Identifier: NCT00917982     History of Changes
Other Study ID Numbers: 8801 
Study First Received: June 10, 2009
Last Updated: June 10, 2009
Health Authority: Iran: Ethics Committee

Additional relevant MeSH terms:
Strabismus
Ocular Motility Disorders
Cranial Nerve Diseases
Nervous System Diseases
Eye Diseases

ClinicalTrials.gov processed this record on December 09, 2016